Literature DB >> 23274463

Alzheimer's disease market: hope deferred.

Zelicia Gerald1, Waldemar Ockert.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23274463     DOI： 10.1038/nrd3922

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Sting of Alzheimer's failures offset by upcoming prevention trials.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694
  1 in total
  4 in total

Review 1.  Prion-like propagation of protein aggregation and related therapeutic strategies.

Authors:  Sarah K Kaufman; Marc I Diamond
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 2.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

Review 3.  Molecular mechanisms of proteinopathies across neurodegenerative disease: a review.

Authors:  Alexander P Marsh
Journal:  Neurol Res Pract       Date:  2019-09-16

4.  Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.

Authors:  Kira S Sheinerman; Vladimir G Tsivinsky; Laila Abdullah; Fiona Crawford; Samuil R Umansky
Journal:  Aging (Albany NY)       Date:  2013-12       Impact factor: 5.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.